Vidac Pharma Holding (STU:T9G) Scaled Net Operating Assets : -6.45 (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Vidac Pharma Holding Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Vidac Pharma Holding's operating assets for the quarter that ended in Jun. 2024 was €0.03 Mil. Vidac Pharma Holding's operating liabilities for the quarter that ended in Jun. 2024 was €0.92 Mil. Vidac Pharma Holding's Total Assets for the quarter that ended in Dec. 2023 was €0.14 Mil. Therefore, Vidac Pharma Holding's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was -6.45.

Vidac Pharma Holding Scaled Net Operating Assets Historical Data

The historical data trend for Vidac Pharma Holding's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vidac Pharma Holding Scaled Net Operating Assets Chart

Vidac Pharma Holding Annual Data

Trend

Dec21

Dec22

Dec23

Scaled Net Operating Assets

-1.37

-2.09

-14.50

Vidac Pharma Holding Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23	Jun24
Scaled Net Operating Assets	-0.66	-1.29	-9.83	-23.73	-6.45

Competitive Comparison of Vidac Pharma Holding's Scaled Net Operating Assets

For the Biotechnology subindustry, Vidac Pharma Holding's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vidac Pharma Holding's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vidac Pharma Holding's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Vidac Pharma Holding's Scaled Net Operating Assets falls into.

Vidac Pharma Holding Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Vidac Pharma Holding's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(0.068	-	0.851)	/	0.054
=	-14.50

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.138	-	0.07
=	0.068

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.016	-	0	-	0.165
=	0.851

Vidac Pharma Holding's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(0.026	-	0.916)	/	0.138
=	-6.45

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.109	-	0.083
=	0.026

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.246	-	0	-	0.33
=	0.916

Vidac Pharma Holding Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Vidac Pharma Holding's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Vidac Pharma Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vidac Pharma Holding PLC (STU:T9G) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Wenlock Road, 20-22, London, GBR, N1 7GU

Website

https://www.vidacpharma.com

Vidac Pharma Holding PLC is a clinical-stage biopharmaceutical company developing first-in-class oncologic and onco-dermatologic therapies. Its drug, VDA-1102, is at the clinical development stage as an ointment for patients with actinic keratosis, an early form of skin cancer, and in a separate trial for an indication of cutaneous T-cell lymphoma (CTCL). A second molecule, VDA-1275, with possible application for a wide range of solid tumors.

Vidac Pharma Holding Headlines

No Headlines